Catalent Stock Price, News & Analysis (NYSE:CTLT)

$42.42 -0.63 (-1.46 %)
(As of 01/19/2018 04:19 AM ET)
Previous Close$43.05
Today's Range$42.14 - $43.02
52-Week Range$25.69 - $43.42
Volume591,800 shs
Average Volume664,250 shs
Market Capitalization$5.67 billion
P/E Ratio48.76
Dividend YieldN/A
Beta1.41

About Catalent (NYSE:CTLT)

Catalent logoCatalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Receive CTLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CTLT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorMedical
SymbolNYSE:CTLT
CUSIPN/A
Phone732-537-6200

Debt

Debt-to-Equity Ratio2.01%
Current Ratio2.91%
Quick Ratio2.49%

Price-To-Earnings

Trailing P/E Ratio48.7591811400131
Forward P/E Ratio28.86
P/E Growth2.71

Sales & Book Value

Annual Sales$2.08 billion
Price / Sales2.72
Cash Flow$2.58 per share
Price / Cash16.44
Book Value$5.79 per share
Price / Book7.33

Profitability

Trailing EPS$0.87
Net Income$109.80 million
Net Margins5.01%
Return on Equity23.97%
Return on Assets5.24%

Miscellaneous

Employees10,800
Outstanding Shares132,860,000

Catalent (NYSE:CTLT) Frequently Asked Questions

What is Catalent's stock symbol?

Catalent trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTLT."

How were Catalent's earnings last quarter?

Catalent Inc (NYSE:CTLT) announced its quarterly earnings data on Monday, November, 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. The business earned $543.90 million during the quarter, compared to the consensus estimate of $490.75 million. Catalent had a return on equity of 23.97% and a net margin of 5.01%. Catalent's revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.16 EPS. View Catalent's Earnings History.

When will Catalent make its next earnings announcement?

Catalent is scheduled to release their next quarterly earnings announcement on Monday, February, 5th 2018. View Earnings Estimates for Catalent.

Where is Catalent's stock going? Where will Catalent's stock price be in 2018?

9 analysts have issued 12 month price objectives for Catalent's shares. Their predictions range from $38.00 to $50.00. On average, they expect Catalent's stock price to reach $44.00 in the next twelve months. View Analyst Ratings for Catalent.

Who are some of Catalent's key competitors?

Who are Catalent's key executives?

Catalent's management team includes the folowing people:

  • John R. Chiminski, Chairman of the Board, President, Chief Executive Officer (Age 53)
  • Matthew M. Walsh CPA, Chief Financial Officer, Executive Vice President (Age 51)
  • Aristippos Gennadios Ph.D., President - Softgel Technologies (Age 52)
  • Wetteny Joseph, President - Clinical Supply Services (Age 45)
  • Barry B. Littlejohns, President - Drug Delivery Solutions (Age 51)
  • Steven L. Fasman, Senior Vice President, General Counsel and Corporate Secretary (Age 55)
  • William Downie, Senior Vice President - Global Marketing & Sales (Age 50)
  • Lance Miyamoto, Senior Vice President - Global Human Resources (Age 62)
  • Christine Dolan, Senior Vice President - Product Development (Age 49)
  • Scott Gunther, Senior Vice President - Quality & Regulatory Affairs (Age 50)

Who owns Catalent stock?

Catalent's stock is owned by a number of of institutional and retail investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.89%), CWM LLC (0.06%), Louisiana State Employees Retirement System (0.03%), Bank of Montreal Can (0.01%), CAPROCK Group Inc. (0.00%) and First Bank & Trust (0.00%). Company insiders that own Catalent stock include Blackstone Management Associat, Christine Dolan, Donald E Morel, Jr, John R Chiminski, Matthew M Walsh, Sharon Johnson and Uwe Roehrhoff. View Institutional Ownership Trends for Catalent.

Who sold Catalent stock? Who is selling Catalent stock?

Catalent's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Louisiana State Employees Retirement System. Company insiders that have sold Catalent company stock in the last year include Christine Dolan, John R Chiminski and Sharon Johnson. View Insider Buying and Selling for Catalent.

Who bought Catalent stock? Who is buying Catalent stock?

Catalent's stock was purchased by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., CWM LLC, CAPROCK Group Inc. and First Bank & Trust. Company insiders that have bought Catalent stock in the last two years include Donald E Morel, Jr and Uwe Roehrhoff. View Insider Buying and Selling for Catalent.

How do I buy Catalent stock?

Shares of Catalent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Catalent's stock price today?

One share of Catalent stock can currently be purchased for approximately $42.42.

How big of a company is Catalent?

Catalent has a market capitalization of $5.67 billion and generates $2.08 billion in revenue each year. The company earns $109.80 million in net income (profit) each year or $0.87 on an earnings per share basis. Catalent employs 10,800 workers across the globe.

How can I contact Catalent?

Catalent's mailing address is 14 SCHOOLHOUSE ROAD, SOMERSET NJ, 08873. The company can be reached via phone at 732-537-6200 or via email at [email protected]


MarketBeat Community Rating for Catalent (CTLT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  182 (Vote Outperform)
Underperform Votes:  203 (Vote Underperform)
Total Votes:  385
MarketBeat's community ratings are surveys of what our community members think about Catalent and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Catalent (NYSE:CTLT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.702.782.672.63
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.00$44.00$40.75$30.83
Price Target Upside: 5.31% upside11.28% upside3.98% upside13.99% downside

Catalent (NYSE:CTLT) Consensus Price Target History

Price Target History for Catalent (NYSE:CTLT)

Catalent (NYSE:CTLT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018First AnalysisInitiated CoverageEqual WeightLowView Rating Details
12/13/2017Royal Bank of CanadaInitiated CoverageOutperform$46.00LowView Rating Details
11/7/2017Piper Jaffray CompaniesBoost Price TargetOverweight$45.00 -> $50.00N/AView Rating Details
10/23/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
9/21/2017Morgan StanleyUpgradeEqual Weight -> Overweight$29.00 -> $48.00HighView Rating Details
9/20/2017Bank of AmericaReiterated RatingBuy$40.00 -> $45.00LowView Rating Details
9/20/2017Wells Fargo & CoBoost Price TargetOutperform$39.00 -> $43.00LowView Rating Details
8/29/2017William BlairReiterated RatingOurperformHighView Rating Details
8/29/2017Jefferies GroupReiterated RatingHold$35.00 -> $38.00HighView Rating Details
8/29/2017JPMorgan Chase & Co.Reiterated RatingBuy$40.00HighView Rating Details
12/1/2016Goldman Sachs GroupInitiated CoverageNeutral$25.00N/AView Rating Details
10/20/2016KeyCorpInitiated CoverageOverweight$29.00N/AView Rating Details
10/18/2016StephensInitiated CoverageOverweight$31.00N/AView Rating Details
2/10/2016Deutsche BankLower Price TargetHold$31.00 -> $24.00N/AView Rating Details
(Data available from 1/19/2016 forward)

Earnings

Catalent (NYSE:CTLT) Earnings History and Estimates Chart

Earnings by Quarter for Catalent (NYSE:CTLT)

Catalent (NYSE CTLT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018N/AView Earnings Details
11/6/2017Q1 2018$0.20$0.21$490.75 million$543.90 millionViewN/AView Earnings Details
8/28/2017Q4 2017$0.57$0.65$547.48 million$616.90 millionViewN/AView Earnings Details
5/4/2017Q3 2017$0.36$0.38$470.95 million$532.60 millionViewListenView Earnings Details
2/6/2017Q217$0.27$0.27$474.07 million$483.70 millionViewListenView Earnings Details
11/7/2016Q117$0.13$0.16$430.26 million$442.20 millionViewListenView Earnings Details
8/29/2016Q416$0.53$0.52$498.06 million$532.20 millionViewListenView Earnings Details
5/4/2016Q316$0.31$0.20$425.92 million$438.00 millionViewN/AView Earnings Details
2/9/2016Q216$0.34$0.36$441.99 million$454.90 millionViewN/AView Earnings Details
11/3/2015Q116$0.21$0.14$407.80 million$423.00 millionViewN/AView Earnings Details
9/2/2015Q415$0.58$0.60$496.91 million$510.10 millionViewN/AView Earnings Details
5/5/2015Q3 2015$0.43$0.46$453.25 million$446.60 millionViewN/AView Earnings Details
2/11/2015Q215$0.33$0.44$451.40 million$455.80 millionViewN/AView Earnings Details
11/13/2014Q314$0.20$0.13$411.20 million$418.30 millionViewN/AView Earnings Details
9/4/2014Q4 2014$1.03ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Catalent (NYSE:CTLT) Earnings Estimates

2018 EPS Consensus Estimate: $1.34
2019 EPS Consensus Estimate: $1.76
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20181$0.29$0.29$0.29
Q3 20181$0.42$0.42$0.42
Q4 20181$0.63$0.63$0.63
Q1 20191$0.26$0.26$0.26
Q2 20191$0.38$0.38$0.38
Q3 20191$0.45$0.45$0.45
Q4 20191$0.67$0.67$0.67
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Catalent (NYSE:CTLT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Catalent (NYSE CTLT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.70%
Institutional Ownership Percentage: 99.37%
Insider Trades by Quarter for Catalent (NYSE:CTLT)
Insider Trades by Quarter for Catalent (NYSE:CTLT)

Catalent (NYSE CTLT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/12/2017John R ChiminskiInsiderSell181,458$39.62$7,189,365.96View SEC Filing  
11/21/2017Uwe RoehrhoffDirectorBuy7,500$39.22$294,150.00View SEC Filing  
8/29/2017Christine DolanSVPSell1,594$38.75$61,767.50View SEC Filing  
8/1/2017Christine DolanSVPSell745$34.85$25,963.25View SEC Filing  
4/25/2017Sharon JohnsonInsiderSell9,160$29.00$265,640.00View SEC Filing  
3/20/2017John R. ChiminskiInsiderSell73,819$28.62$2,112,699.78View SEC Filing  
2/15/2017Donald E. Morel, Jr.DirectorBuy10,000$29.27$292,700.00View SEC Filing  
9/9/2016Blackstone Management AssociatMajor ShareholderSell17,100,705$23.58$403,234,623.90View SEC Filing  
6/9/2016Blackstone Management AssociatMajor ShareholderSell8,785,539$24.51$215,333,560.89View SEC Filing  
5/27/2016Matthew M WalshInsiderSell21,197$28.85$611,533.45105,688View SEC Filing  
8/19/2015John R ChiminskiInsiderSell38,505$33.81$1,301,854.05View SEC Filing  
8/17/2015John R ChiminskiInsiderSell35,550$33.80$1,201,590.00View SEC Filing  
7/20/2015John R ChiminskiInsiderSell33,081$29.40$972,581.40View SEC Filing  
7/6/2015John R ChiminskiInsiderSell33,828$29.34$992,513.52View SEC Filing  
6/11/2015Blackstone Management AssociatMajor ShareholderSell1,844,963$28.13$51,898,809.19View SEC Filing  
6/8/2015Blackstone Management AssociatMajor ShareholderSell12,299,753$28.13$345,992,051.89View SEC Filing  
4/1/2015Scott HoultonInsiderSell16,253$30.61$497,504.33View SEC Filing  
3/27/2015Stephen LeonardInsiderSell31,005$30.13$934,180.65View SEC Filing  
2/17/2015Scott HoultonInsiderSell14,538$27.50$399,795.00View SEC Filing  
2/13/2015Scott HoultonInsiderSell1,400$28.28$39,592.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Catalent (NYSE CTLT) News Headlines

Source:
DateHeadline
Catalent (CTLT) Rating Lowered to Hold at Zacks Investment ResearchCatalent (CTLT) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 18 at 10:54 PM
Zacks Investment Research Upgrades Catalent (CTLT) to "Buy"Zacks Investment Research Upgrades Catalent (CTLT) to "Buy"
www.americanbankingnews.com - January 17 at 10:40 PM
Catalent, Inc. Announces Second Quarter Fiscal Year 2018 Earnings Conference WebcastCatalent, Inc. Announces Second Quarter Fiscal Year 2018 Earnings Conference Webcast
finance.yahoo.com - January 16 at 5:03 PM
Catalent Inc (CTLT) Given Consensus Recommendation of "Buy" by BrokeragesCatalent Inc (CTLT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 15 at 11:42 AM
$567.62 Million in Sales Expected for Catalent Inc (CTLT) This Quarter$567.62 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - January 14 at 12:00 PM
William Blair Analysts Boost Earnings Estimates for Catalent Inc (CTLT)William Blair Analysts Boost Earnings Estimates for Catalent Inc (CTLT)
www.americanbankingnews.com - January 12 at 3:40 PM
Catalent Inc (CTLT) Expected to Post Earnings of $0.34 Per ShareCatalent Inc (CTLT) Expected to Post Earnings of $0.34 Per Share
www.americanbankingnews.com - January 12 at 5:14 AM
Q2 2018 EPS Estimates for Catalent Inc (CTLT) Cut by William BlairQ2 2018 EPS Estimates for Catalent Inc (CTLT) Cut by William Blair
www.americanbankingnews.com - January 11 at 12:40 PM
Catalent (CTLT) & Valeant Pharmaceuticals Intl (VRX) Critical AnalysisCatalent (CTLT) & Valeant Pharmaceuticals Intl (VRX) Critical Analysis
www.americanbankingnews.com - January 11 at 5:36 AM
Zacks Investment Research Upgrades Catalent (CTLT) to HoldZacks Investment Research Upgrades Catalent (CTLT) to Hold
www.americanbankingnews.com - January 9 at 8:58 PM
Catalent (CTLT) Now Covered by First AnalysisCatalent (CTLT) Now Covered by First Analysis
www.americanbankingnews.com - January 5 at 4:52 PM
Analyzing Catalent (CTLT) & Neuralstem (CUR)Analyzing Catalent (CTLT) & Neuralstem (CUR)
www.americanbankingnews.com - January 4 at 1:32 PM
New Strong Sell Stocks for December 29th - NasdaqNew Strong Sell Stocks for December 29th - Nasdaq
www.nasdaq.com - December 29 at 10:19 AM
New Strong Sell Stocks for December 29thNew Strong Sell Stocks for December 29th
finance.yahoo.com - December 29 at 10:19 AM
$567.30 Million in Sales Expected for Catalent Inc (CTLT) This Quarter$567.30 Million in Sales Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - December 28 at 2:26 PM
ETFs with exposure to Catalent, Inc. : December 27, 2017ETFs with exposure to Catalent, Inc. : December 27, 2017
finance.yahoo.com - December 28 at 6:10 AM
Comparing Catalent (CTLT) & Its RivalsComparing Catalent (CTLT) & Its Rivals
www.americanbankingnews.com - December 28 at 1:10 AM
$0.34 EPS Expected for Catalent Inc (CTLT) This Quarter$0.34 EPS Expected for Catalent Inc (CTLT) This Quarter
www.americanbankingnews.com - December 26 at 6:18 PM
Reviewing Catalent (CTLT) and Its RivalsReviewing Catalent (CTLT) and Its Rivals
www.americanbankingnews.com - December 26 at 9:24 AM
Catalent, Inc. :CTLT-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017Catalent, Inc. :CTLT-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 9:15 AM
Comparing Catalent (CTLT) and Its CompetitorsComparing Catalent (CTLT) and Its Competitors
www.americanbankingnews.com - December 25 at 7:29 PM
Reviewing Catalent (CTLT) & Its CompetitorsReviewing Catalent (CTLT) & Its Competitors
www.americanbankingnews.com - December 23 at 9:28 AM
Catalent (CTLT) and Its Peers Head to Head AnalysisCatalent (CTLT) and Its Peers Head to Head Analysis
www.americanbankingnews.com - December 22 at 1:24 PM
Catalent Inc (CTLT) Given Average Recommendation of "Hold" by BrokeragesCatalent Inc (CTLT) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 21 at 11:52 AM
Catalent (CTLT) vs. Its Peers Critical ReviewCatalent (CTLT) vs. Its Peers Critical Review
www.americanbankingnews.com - December 21 at 5:16 AM
Zacks Investment Research Lowers Catalent (CTLT) to SellZacks Investment Research Lowers Catalent (CTLT) to Sell
www.americanbankingnews.com - December 20 at 6:34 PM
Catalent (CTLT) versus Its Competitors Head to Head SurveyCatalent (CTLT) versus Its Competitors Head to Head Survey
www.americanbankingnews.com - December 20 at 9:32 AM
Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : December 18, 2017Catalent, Inc. breached its 50 day moving average in a Bullish Manner : CTLT-US : December 18, 2017
finance.yahoo.com - December 18 at 10:08 AM
Insider Selling: Catalent Inc (CTLT) Insider Sells 181,458 Shares of StockInsider Selling: Catalent Inc (CTLT) Insider Sells 181,458 Shares of Stock
www.americanbankingnews.com - December 13 at 5:26 PM
Catalent Inc (CTLT) Chair, President & CEO John R Chiminski Sold $7.2 million of SharesCatalent Inc (CTLT) Chair, President & CEO John R Chiminski Sold $7.2 million of Shares
finance.yahoo.com - December 13 at 5:15 PM
Catalent (CTLT) Coverage Initiated at Royal Bank of CanadaCatalent (CTLT) Coverage Initiated at Royal Bank of Canada
www.americanbankingnews.com - December 13 at 8:40 AM
Head to Head Comparison: Catalent (CTLT) & Its PeersHead to Head Comparison: Catalent (CTLT) & Its Peers
www.americanbankingnews.com - December 13 at 5:12 AM
Catalent (CTLT) versus Its Competitors Critical SurveyCatalent (CTLT) versus Its Competitors Critical Survey
www.americanbankingnews.com - December 12 at 9:18 AM
Financial Review: Catalent (CTLT) & Its PeersFinancial Review: Catalent (CTLT) & Its Peers
www.americanbankingnews.com - December 10 at 9:08 PM
 Brokerages Anticipate Catalent, Inc. (CTLT) Will Announce Earnings of $0.34 Per Share Brokerages Anticipate Catalent, Inc. (CTLT) Will Announce Earnings of $0.34 Per Share
www.americanbankingnews.com - December 9 at 1:20 AM
Stocks Showing Rising Market Leadership: Catalent Earns 83 RS RatingStocks Showing Rising Market Leadership: Catalent Earns 83 RS Rating
finance.yahoo.com - December 7 at 5:28 PM
Contrasting Catalent (CTLT) and Its RivalsContrasting Catalent (CTLT) and Its Rivals
www.americanbankingnews.com - December 7 at 1:22 AM
Catalent (CTLT) Downgraded to Hold at ValuEngineCatalent (CTLT) Downgraded to Hold at ValuEngine
www.americanbankingnews.com - December 3 at 5:54 PM
Head to Head Comparison: Catalent (CTLT) vs. Its CompetitorsHead to Head Comparison: Catalent (CTLT) vs. Its Competitors
www.americanbankingnews.com - December 2 at 1:06 PM
Catalent, Inc. (CTLT) Given Consensus Recommendation of "Buy" by BrokeragesCatalent, Inc. (CTLT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 26 at 2:21 PM
Catalent, Inc. (CTLT) Downgraded by BidaskClub to HoldCatalent, Inc. (CTLT) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - November 26 at 8:16 AM
Catalent, Inc. (CTLT) Director Buys $294,150.00 in StockCatalent, Inc. (CTLT) Director Buys $294,150.00 in Stock
www.americanbankingnews.com - November 22 at 7:57 PM
Stock Performance Review on Generic Drugs Industry -- pSivida, Tetraphase Pharma, Catalent, and LannettStock Performance Review on Generic Drugs Industry -- pSivida, Tetraphase Pharma, Catalent, and Lannett
www.bizjournals.com - November 22 at 6:20 PM
Catalents Acquisition Of Cook Pharmica Overshadows EarningsCatalent's Acquisition Of Cook Pharmica Overshadows Earnings
seekingalpha.com - November 21 at 10:50 PM
Zacks: Analysts Expect Catalent, Inc. (CTLT) Will Post Earnings of $0.34 Per ShareZacks: Analysts Expect Catalent, Inc. (CTLT) Will Post Earnings of $0.34 Per Share
www.americanbankingnews.com - November 21 at 3:28 AM
Catalent (CTLT) Announces Share Buyback PlanCatalent (CTLT) Announces Share Buyback Plan
www.americanbankingnews.com - November 15 at 11:55 AM
Finish Line and Zions slide while Movado and Lockheed riseFinish Line and Zions slide while Movado and Lockheed rise
marketbeat.com - August 29 at 4:36 PM
Catalent beats Street 3Q forecastsCatalent beats Street 3Q forecasts
marketbeat.com - May 4 at 7:58 PM
CATALENT, INC. Files SEC form 8-K/A, Change in Directors or Principal OfficersCATALENT, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
biz.yahoo.com - February 9 at 5:02 PM
Catalent (CTLT) Q2 2017 Results - Earnings Call TranscriptCatalent (CTLT) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - February 7 at 2:39 AM

SEC Filings

Catalent (NYSE:CTLT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Catalent (NYSE:CTLT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Catalent (NYSE CTLT) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.